Skip to main content

Animations

MJFF Publications

2951 - 2975 of 6230 Results
Title
Year
  • Year
  • 2016
  • 2020
  • 2023
  • 2022
  • 2023
  • 2023
  • 2023
  • 2025
  • 2021
  • 2016
  • 2024
  • 2019
  • 2019
  • 2021
  • 2020
  • 2018
  • 2020
  • 2020
  • 2020
  • 2021
  • 2019
  • 2021
  • 2024
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.005
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/bpa.13196
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20220161
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/ejn.15917
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Structure-based design and characterization of Parkin-activating mutations
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202201419
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Sex differences in the diagnosis latency of Parkinson's disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00189-4
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 925
  • Summary Details
    OPEN
    Title: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.96699
    Citation Count: 1
  • Summary Details
    OPEN
    Title: [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-019-04369-6
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells
    Journal Name: Oxidative Medicine and Cellular Longevity
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2019/4246350
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson disease
    Journal Name: Interdisciplinary Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.inat.2021.101224
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screening
    Journal Name: Chemical Science
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1039/d0sc02159h
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016
    Best OA location URL:
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28318
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00524
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28382
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg6677
    Citation Count: 45
  • Summary Details
    OPEN
    Title: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stress
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1096/fj.201900830r
    Citation Count: 90
  • Summary Details
    OPEN
    Title: echolocatoR: an automated end-to-end statistical and functional genomic fine-mapping pipeline
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Pharmacological targeting of dopamine D1 or D2 receptors evokes a rapid‐onset parkinsonian motor phenotype in mice
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16622
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Is Levodopa Response a Valid Indicator of Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28406
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.101720
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.